Praxis Precision Medicines Inc (PRAX)

Nov 02, 2025

Using Python tools to backtest Praxis Precision Medicines Inc. strategiesWeekly Risk Summary & Real-Time Chart Pattern Alerts - newser.com

Nov 02, 2025

Nov 02, 2025

Is Praxis Precision Medicines Inc. stock near bottom after declineJuly 2025 Trade Ideas & Fast Moving Stock Trade Plans - newser.com

Nov 02, 2025

Nov 02, 2025

How Praxis Precision Medicines Inc. stock valuations compare to rivalsTrade Analysis Summary & Long-Term Capital Growth Strategies - newser.com

Nov 02, 2025

Nov 01, 2025

Is a relief rally coming for Praxis Precision Medicines Inc. holdersJuly 2025 Momentum & Entry and Exit Point Strategies - newser.com

Nov 01, 2025

Nov 01, 2025

Can Praxis Precision Medicines Inc. stock deliver surprise earnings beatJuly 2025 Pullbacks & Detailed Earnings Play Strategies - newser.com

Nov 01, 2025

Nov 01, 2025

Published on: 2025-11-01 00:59:14 - newser.com

Nov 01, 2025

Oct 31, 2025

Praxis Precision Medicines (NASDAQ:PRAX) Reaches New 1-Year HighHere's What Happened - MarketBeat

Oct 31, 2025

Oct 31, 2025

Praxis Precision Medicines stock hits 52-week high at $206.36 By Investing.com - Investing.com Australia

Oct 31, 2025

Oct 31, 2025

What institutional flow reveals about Praxis Precision Medicines Inc.Forecast Cut & Real-Time Market Trend Scan - newser.com

Oct 31, 2025

Oct 31, 2025

Does Praxis Precision Medicines Inc. qualify in momentum factor screening2025 Institutional Moves & High Yield Stock Recommendations - newser.com

Oct 31, 2025

Oct 31, 2025

Published on: 2025-10-31 03:19:21 - newser.com

Oct 31, 2025

Oct 31, 2025

What valuation multiples suggest for Praxis Precision Medicines Inc. stockDividend Hike & Proven Capital Preservation Tips - newser.com

Oct 31, 2025

Oct 31, 2025

Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat

Oct 31, 2025

Oct 30, 2025

Praxis Precision Medicines stock hits 52-week high at $206.36 - Investing.com

Oct 30, 2025

Oct 30, 2025

Praxis Precision Medicines (PRAX) Projected to Post Quarterly Earnings on Wednesday - MarketBeat

Oct 30, 2025

Oct 29, 2025

Published on: 2025-10-29 21:58:45 - newser.com

Oct 29, 2025

Oct 29, 2025

What’s Happening With Praxis Stock? - Trefis

Oct 29, 2025

Oct 29, 2025

Does Positive Phase 3 Data for Ulixacaltamide Transform the Outlook for Praxis Precision Medicines (PRAX)? - Sahm

Oct 29, 2025

Oct 29, 2025

Praxis Precision Medicines, Inc. (PRAX) Expected to Beat Earnings Estimates: Should You Buy? - Yahoo Finance

Oct 29, 2025

Oct 29, 2025

Published on: 2025-10-29 03:41:05 - newser.com

Oct 29, 2025

Oct 29, 2025

Praxis Precision Medicines’ PRAX-562 Trial: A Potential Game-Changer for Epileptic Encephalopathies - TipRanks

Oct 29, 2025

Oct 28, 2025

Praxis Precision Medicines (PRAX) Price Target Increased by 153.57% to 258.64 - Nasdaq

Oct 28, 2025

Oct 28, 2025

Praxis Precision Medicines Signs New Sales Agreement - MSN

Oct 28, 2025

Oct 28, 2025

Praxis Precision Medicines, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo

Oct 28, 2025

Oct 28, 2025

Applying big data sentiment scoring on Praxis Precision Medicines Inc.Weekly Profit Analysis & Community Verified Watchlist Alerts - newser.com

Oct 28, 2025

Oct 28, 2025

Praxis Precision Medicines (PRAX): Evaluating Valuation After Positive Phase 3 Results for Essential Tremor Drug - Sahm

Oct 28, 2025

Oct 27, 2025

Published on: 2025-10-27 23:27:23 - fcp.pa.gov.br

Oct 27, 2025

Oct 27, 2025

How to use Fibonacci retracement on Praxis Precision Medicines Inc.Watch List & Trade Opportunity Analysis - newser.com

Oct 27, 2025

Oct 27, 2025

Praxis Precision Medicines Advances Elsunersen Trial for Pediatric Epileptic Encephalopathy - TipRanks

Oct 27, 2025

Oct 27, 2025

Praxis Precision Medicines Advances Phase 3 Trial for DEE Treatment - TipRanks

Oct 27, 2025

Oct 27, 2025

Praxis Precision Medicines Advances Phase 3 Study for Essential Tremor Treatment - TipRanks

Oct 27, 2025